Neovascular Age Related Macular Degeneration Wet Amd clinical trials

Explore recruiting neovascular age related macular degeneration wet amd clinical trials.

Recruiting neovascular age related macular degeneration wet amd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neovascular Age Related Macular Degeneration Wet Amd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and Safety of Intravitreal OPT-302 in Combination with Ranibizumab, Compared with Ranibizumab Alone, in Participants with Neovascular Age-related Macular Degeneration (nAMD)

Hungary, Denmark, Czechia, Poland, Latvia, Germany +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with Aflibercept Alone, in Participants with Neovascular Age-related Macular Degeneration (nAMD)

Czechia, Bulgaria, Croatia, Netherlands, Poland, Estonia +10 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Neovascular Age Related Macular Degeneration Wet Amd trials by city

Neovascular Age Related Macular Degeneration Wet Amd in Toronto Neovascular Age Related Macular Degeneration Wet Amd in Vancouver Neovascular Age Related Macular Degeneration Wet Amd in Montreal Neovascular Age Related Macular Degeneration Wet Amd in Calgary Neovascular Age Related Macular Degeneration Wet Amd in Edmonton Neovascular Age Related Macular Degeneration Wet Amd in Ottawa Neovascular Age Related Macular Degeneration Wet Amd in Winnipeg Neovascular Age Related Macular Degeneration Wet Amd in Quebec City Neovascular Age Related Macular Degeneration Wet Amd in Hamilton Neovascular Age Related Macular Degeneration Wet Amd in Kitchener Neovascular Age Related Macular Degeneration Wet Amd in London Neovascular Age Related Macular Degeneration Wet Amd in Halifax Neovascular Age Related Macular Degeneration Wet Amd in New York Neovascular Age Related Macular Degeneration Wet Amd in Los Angeles Neovascular Age Related Macular Degeneration Wet Amd in Chicago Neovascular Age Related Macular Degeneration Wet Amd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease